NCT00454363 2020-04-03Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerNational Cancer Institute (NCI)Phase 2 Completed52 enrolled 11 charts
NCT00869050 2016-07-25Capecitabine and Temozolomide for Neuroendocrine CancersColumbia UniversityPhase 2 Completed41 enrolled 9 charts